Form 4 for IRMD IRADIMED CORP
Accepted 2021-12-08 00:00:00 ET · period of report 2021-12-04 · accession 0000898432-21-000756 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-12-08 | 2021-12-04 | IRMD | Scott Christopher K. | COO, CFO, Sec | M - OptEx | — | +2,952 | 31.5K | +10% | — |
| D | 2021-12-08 | 2021-12-04 | IRMD | Scott Christopher K. | COO, CFO, Sec | F - Tax | $44.41 | -1,162 | 30.4K | -4% | -$51.6K |
| D | 2021-12-08 | 2021-12-04 | IRMD | Scott Christopher K. | COO, CFO, Sec | M - OptEx | $0.00 | -2,952 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-04 | M | A | 2,952 | — | 31,547 | D | — | — | (F1) Restricted stock units convert into common stock on a one-for-one basis. |
| 2 | Common | Common Stock | 2021-12-04 | F | D | 1,162 | $44.41 | 30,385 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-12-04 | M | D | 2,952 | $0.00 | 0 | D | — · — to — | 2,952 Common Stock | (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) On December 4, 2017, the reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on December 4, 2018. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested. |